FDA accepts NDA for Sydnexis's low-dose atropine for pediatric myopia
Pipeline

FDA accepts NDA for Sydnexis's low-dose atropine for pediatric myopia

Once-daily drop features unique establishing excipient to avoid rapid atropine degradation; may become first eye drop with 3-year shelf-life.
AAO report evaluates validity of multifocal CLs for myopia
Research

AAO report evaluates validity of multifocal CLs for myopia

Report demonstrates efficacy of multifocal soft CLs for myopia control compared to single-vision spectacles and CLs.
Oculus introduces myopia software to Pentacam AXL Wave
Products

Oculus introduces myopia software to Pentacam AXL Wave

Newest software package for optometrists offers improved accuracy and safety for myopia management, screenings, and ortho-k fittings in a single device.
Ocumetra showcases all-in-one myopia management software
Products

Ocumetra showcases all-in-one myopia management software

The mEYE Suite is designed to enhance patient engagement, provide axial length estimates, and enable streamlined decision-making and predictive analytics.
CooperVision announces myopia management updates and plans
Business

CooperVision announces myopia management updates and plans

Company creates new position of Vice President, Myopia Management & Cornea Care and previews clinical investigation plans.
Hoya Vision Care launches expanded power range for MiYOSMART lenses for high pediatric myopia
Products

Hoya Vision Care launches expanded power range for MiYOSMART lenses for high pediatric myopia

New extension offers spectacles in larger diameters and with optimized lens edge thickness, accommodating both high myopia and astigmatism.
Pediatric study supports multifocal contact lens method for slowing myopia
Research

Pediatric study supports multifocal contact lens method for slowing myopia

Follow-up to the BLINK trial evaluates potential benefits and lasting effects of MF lens wear among children fitted at younger ages and lasting through teenage years.
Eyenovia's phase 3 pediatric myopia trial fails primary goal
Pipeline

Eyenovia's phase 3 pediatric myopia trial fails primary goal

Company reports insignificant findings on drug-device combo of low-dose atropine and its Optejet system; announces next steps.
Omnibus model identifies framework for effective myopia management
Research

Omnibus model identifies framework for effective myopia management

New research out of the 2024 AAOpt meeting investigates two key—but broad—areas of disease progression among pediatric patients.
How does peripheral defocus impact pediatric myopia development?
Research

How does peripheral defocus impact pediatric myopia development?

Researchers explore whether peripheral defocus of the horizontal direction increases the risk of myopia development in children.
Is weekly or daily atropine more effective for pediatric myopia management?
Research

Is weekly or daily atropine more effective for pediatric myopia management?

Weekly 1% atropine drops may be a potentially effective treatment in younger and mildly myopic patients.
Hoya reports 8-year data on DIMS spectacle lenses for pediatric myopia
Research

Hoya reports 8-year data on DIMS spectacle lenses for pediatric myopia

Long-term study evaluated myopia control effect and user experience of patients wearing HOYA’s MiYOSMART spectacle lenses.
Global Myopia Awareness Coalition adds international members
Business

Global Myopia Awareness Coalition adds international members

The Singapore Optometric Association and Optometry Australia have joined the industry coalition’s fight against myopia.
Short-term sunlight exposure impacts pediatric myopia development
Research

Short-term sunlight exposure impacts pediatric myopia development

New study investigates how sun exposure may impact fundus blood flow perfusion.
How effective is ortho-k in slowing AL growth for pediatric myopia?
Research

How effective is ortho-k in slowing AL growth for pediatric myopia?

Ortho-k for myopia control was very effective and not effective in 40% and 25% of study participants respectively.
Physically active kids less likely to develop myopia
Research

Physically active kids less likely to develop myopia

Cross-sectional study investigates physical activity’s effect on childhood myopia prevalence
Data supports prior findings on red light therapy for pediatric myopia management
Research

Data supports prior findings on red light therapy for pediatric myopia management

New research assesses the efficacy and safety of 650 nm LLRL for myopia treatment in children.
The Myopia Collective selects over 60 ODs to lead US myopia control efforts
Events

The Myopia Collective selects over 60 ODs to lead US myopia control efforts

Inaugural cohort of Change Agents from across the country will lead the charge to disrupt the current standard of pediatric myopia care.
Myopia Management Navigator targets global advancements in care
Research

Myopia Management Navigator targets global advancements in care

Myopia expert shares clinical input on this user-friendly digital platform designed for ECPs and patients.
Atropine 0.05% for myopia shows promise in 5-year LAMP study
Research

Atropine 0.05% for myopia shows promise in 5-year LAMP study

Extended data builds on prior 1-year and 3-year findings regarding atropine effectiveness for childhood myopia.